NOV 30, 2021 11:00 AM PST

Clinical value of measurable residual disease assessment in multiple myeloma

Sponsored by: Cytognos
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  November 30, 2021
Time: 11:00am (PST),  2:00pm (EST)
 
In recent years, Measurable Residual Disease (MRD) assessment in Multiple Myeloma (MM) has gained increasing relevance. After more than a decade of active research in the field, new drugs and treatment strategies have emerged. They have significantly modified the way we approach the disease by transforming deep and sustained responses into a realistic goal.
 
Thanks to the technological development, classic detection approaches like conventional flow cytometry or ASO-PCR, have evolved into next generation methodologies that have supported MRD to become a more widely used prognostic indicator and clinical decision-making tool. Other alternative methods, like liquid biopsy or mass spectrometry, are also making their way to the front-line of treatment monitoring, but their efficient integration in patient management is yet to be defined.
 
Lastly, substantial efforts are ongoing to recognize the value of standardization of MRD assessment. Following standardized methodologies can accelerate the obtention of clinically meaningful results and thus, lead to further optimized therapies.
 
Learning Objectives:
 
  • Analyze the bases of MRD detection in MM patients with available methodologies.
  • Discuss the clinically useful information that MRD provides and how MRD testing can be incorporated in routine clinical practice.
  • Assess recent advances and new opportunities in the field of Multiple Myeloma patient monitoring.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources